Further, another study investigating the influence of PromogranTM on diabetic foot ulcers showed that patients had significantly less gelatinase, elastase, and plasmin in the wound as well as reductions in matrix metalloproteinase‐2 compared to those treated with hydrocolloid dressings.27 The gene discussed is PLG; the disease is diabetic foot.